Journal of Pediatric Biochemistry 2010; 01(04): 309-324
DOI: 10.1055/s-0036-1586382
Review Article
Georg Thieme Verlag KG Stuttgart – New York

Hyperglycemia-induced oxidative-stress, apoptosis, and embryopathy

Robert R. Miller Jr
a   Department of Biology, Hillsdale College, Hillsdale, 278 N. West St., Dow Science 213, MI 49242, USA. Tel.: +1 517 6072393; Fax: +1 517 6072252; E-mail: rmiller2@hillsdale.edu
› Author Affiliations

Subject Editor:
Further Information

Publication History

24 March 2011

06 April 2011

Publication Date:
01 August 2016 (online)

Abstract

As the incidence of both type-1 and type-2 diabetes increases, more diabetes-related complications are being observed in pediatric patients. However, some diabetes-related issues in pediatric patients may be a carry-over or consequence of gestational or fetal diabetes. Elevated maternal glucose levels have been associated with increased incidence of spontaneous abortions, perinatal mortality, stillbirths, and congenital malformations. A few of these congenital malformations (embryopathy) in both humans and animals include skin discoloration; webbed toes; cleft lips and palates; congenital heart defects; and neural tube defects. While neural tube defects and congenital heart defects are the most frequent consequence of embryonic / fetal hyperglycemia, hyperglycemia-induced hepatic and renal developmental problems are also known. Hyperglycemia-induced embryopathy has been associated with reduced cell proliferation, oxidative-stress, increased rates of lipid peroxidation coupled with increased homocysteine levels, and apoptosis. Consequently, this review discusses embryonic hyperglycemia-induced reduced embryo viability, increased rates of oxidative-stress, increased lipid peroxidation rates coupled with elevated homocysteine levels, and increased apoptosis rates.